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Purpose: We evaluated the motion-induced dosimetric effects on the field-in-field (FIF) technique 
for whole-breast irradiation (WBI) using actual patient organ motion data obtained from cine 
electronic portal imaging device (cine EPID) images during treatment.
Materials and Methods: Ten breast cancer patients who received WBI after breast-conserving 
surgery were selected. The static FIF (SFIF) plan involved the application of two parallel opposing 
tangential and boost FIFs. To obtain the amplitude of the internal organ motion during treatment, 
cine EPID images were acquired five times for each patient. The outside contour of the breast 
(OCB) and chest wall (CW) contour were tracked using in-house motion analysis software. 
Intrafractional organ motion was analyzed. The dynamic FIF (DFIF) reflecting intrafractional organ 
motion incorporated into the SFIF plan was calculated and compared with the SFIF in terms of the 
dose homogeneity index (DHI90/10) for the target and V20 for the ipsilateral lung. 
Results: The average motion amplitudes along the X and Y directions were 1.84±1.09 mm and 
0.69±0.50 mm for OCB and 1.88±1.07 mm and 1.66±1.49 mm for CW, respectively. The 
maximum motion amplitudes along the X and Y directions were 5.53 and 2.08 mm for OCB and 
5.22 and 6.79 mm for CW, respectively. Significant differences in DHI90/10 values were observed 
between SFIF and DFIF (0.94 vs 0.95, P<0.05) in statistical analysis. The average V20 for the lung in 
the DFIF was slightly higher than that of the SFIF in statistical analysis (19.21 vs 19.00, P<0.05). 
Conclusion: Our findings indicate that the FIF technique can form a safe and effective treatment 
method for WBI. Regular monitoring using cine EPID images can be effective in reducing motion-
induced dosimetric errors.
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Introduction
The whole-breast irradiation (WBI) technique has at-
tracted considerable interest because breast cancer is one 
of the most prevalent cancers worldwide; the number 
of breast cancer patients has rapidly increased in recent 
times.1) WBI has played an important role in minimizing 
the risk of ipsilateral recurrence after breast-conserving 
surgery.2-5) WBI has traditionally been performed with tan-
gential irradiation (TI), which involves the application of 
parallel opposing half-beam wedge fields. Conventional TI 
is very simple and convenient, but dose inhomogeneity in 
the target volume resulting from tissue heterogeneity in the 
irradiated volume and the difference in beam path lengths 
is an unavoidable demerit. Overdosage can lead to un-
wanted cosmetic outcomes and side effects.6,7) In addition, 
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TI is not suitable to modify the beam intensity at specific 
regions, and modification is generally used for reducing 
the radiation dose to normal organs. 
With this background, Oliver et al. employed intensity-
modulated radiation therapy (IMRT) for WBI to obtain a 
homogeneous dose distribution in the target volume and 
reduce dosage to normal healthy tissue.8-11) However, while 
IMRT is advantageous from the dosimetric point of view, 
the technique suffers from the demerits of long planning 
and treatment time, large number of MUs, and relative 
complexity of treatment compared with TI.12) Mihai et al.13) 
introduced the forward intensity-modulated radiation 
therapy (FIMRT) technique for WBI. FIMRT essentially 
involves the application of parallel opposing open fields 
to cover the entire target volume and sub-boost fields, 
which are shaped by a multi-leaf collimator to compensate 
for dose inhomogeneity within the target volume and re-
duce dosage to normal organs. In comparison with IMRT, 
FIMRT offers simplicity of treatment technique, good dose 
homogeneity in the target volume, a small number of MUs, 
and reduced delivery time. Prabhakar et al. examined dif-
ferent types of FIMRT and proposed the field-in-field (FIF) 
technique, which offers all the advantages of the IMRT, 
FIMRT, and TI techniques.14,15) 
The target volume for WBI includes the tumor bed and 
the whole-breast tissue on the CW. The target volume is 
expected to be subject to geometrical uncertainty because 
of the influence of respiratory organ motion.16) The IMRT, 
FIMRT, and FIF techniques are disadvantageous when 
considering organ motion in comparison with simple TI 
because their beams consist of many sub-fields of differ-
ent radiation intensities to obtain the desirable dose dis-
tribution within the treatment volume. Jain et al.17) have 
reported that the organ motion effect is not significant 
from the dosimetric point of view when FIMRT is used for 
WBI. Song et al.18) conducted similar research on the FIF 
technique and reported significant dose variation because 
of respiratory organ motion by applying speculative mo-
tion values (1, 2, and 3 cm) instead of actual patient data. 
However, to the best of our knowledge, no study has ad-
dressed the dosimetric effects of target motion based on 
actual patient motion data with patient-specific treatment 
beam conditions. Thus, the dosimetric effects of respira-
tory organ motion need to be evaluated by applying actual 
patient data for the breast FIF technique to ensure better 
outcomes and safer treatment. We evaluated the motion-
induced dosimetric effects on the breast FIF technique 
using actual patient organ motion data obtained from cine 
electronic portal imaging device (cine EPID) images during 
treatment.
Materials and Methods
1.  Computed tomography simulation and treatment 
planning
Ten breast cancer patients were randomly selected (five 
right-breast and five left-breast cancer patients) for WBI in 
this study after breast-conserving surgery (details are listed 
in Table 1). A planning computed tomography (CT) was 
performed for each patient in the supine position with the 
arm up on the breast board (Medtech, USA). All CT images 
were transferred to the treatment planning system (TPS, 
Pinnacle3, Philips Medical Systems, Milpitas, CA, USA). 
We delineated the clinical target volume (CTV) including 
the tumor bed and breast tissue and organs at risk (OARs) 
including the ipsilateral lung and heart. The FIF technique, 
one of the FIMRT techniques, was applied in combination 
with TI (Fig. 1a) and sub-boost fields (Fig. 1b, c) to improve 
dose distribution, as described below. First, TI beams were 
generated via the application of two open parallel oppos-
ing half-beams (6-MV photons, CL600, Varian, USA). The 
initial dose distribution was calculated with equal beam 
weights. Next, an isodose cloud was displayed on the digi-
tal reconstruction radiograph (DRR). Our plan criterion 
for WBI was that the dose received by the CTV should lie 
in the range of 95% to 107% of the prescribed dose. There-
fore, an isodose cloud outside this range was acquired, 
and the dose was compensated manually using a multi-
leaf collimator (MLC) (Fig. 1). In other words, when the 
CTV received a dose less than 95% of the prescribed dose, 
a sub-field was added to compensate for the dose, and 
when the CTV dose exceeded 107%, shielding was applied 
via the MLC. The total number of sub-fields was limited to 
less than two for the treatment plan of each patient. Fur-
thermore, we ensured that the total beam weight did not 
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exceed 10% of the entire beam weight. A total of 50 Gy with 
25 fractions was prescribed for the CTV.
2. Measurement of intrafractional motion
Cine EPID images were used to measure the intrafrac-
tional motion of the breast. Cine EPID imaging is used to 
obtain continuous images with the beam used in the actual 
treatment with an EPID (aS500, Varian, USA) during treat-
ment, and the technique is suitable for real-time verifica-
tion of organ motion.19) Cine EPID images were obtained 
at a rate of 3.3 frames/s once a week per patient five times 
during the entire treatment schedule.
We developed an in-house motion analysis software 
package to extract the motion of the breast from the ac-
quired sequential cine EPID images (Matlab, MathWorks, 
USA) (Fig. 2). The outside contour of the breast (OCB) and 
the chest wall (CW) at the central axis of the beam were set 
as the region of interest (ROI), and the motion of the ROI in 
the sequential cine EPID was tracked by applying a pattern 
matching algorithm. Variations along the X and Y direc-
tions were measured with respect to the vertical axis of the 
tangential beam direction, and based on these values, the 
maximum amplitude, mean amplitude, and the standard 
deviation were calculated.
a b c
Fig. 1. Design of field-in-field (FIF) 
treat ment plan. The FIF plan in volves 
the application of (a) two tan gen tial 
beams and (b, c) sub-boost fields to 
com pensate for the dose in homo ge-
neity in the target and reduce the lung 
dose.
Table 1. Patients’ characteristics
Patient Age Tumor location Clinical stage Histology
CTV volume  
(cm3)
Ipsilateral lung  
volume (cm3)
1 40 Left T1N1 IDC 340.8 1510.7
2 60 Right T1bN1 IDC 315.4 1272.5
3 40 Left T1N1mi IDC 293.6 1118.1
4 49 Right T1N0 DCIS or IDC 227.3 1368.6
5 47 Left T1N0 IDC 313.3 1009.4
6 40 Right T2N0 IDC 311.4 1104.4
7 38 Right T1N0 IDC 163.5 873.4
8 69 Left T1N0 DCIS 287.7 1118.1
9 59 Left T1N0 IDC 265.9 1026.5
10 50 Right TisN0 DCIS 305.9 1316.8
Median  
(IQR)
48 (40.0 to 
59.3)
299.8 (256.3
to 313.8)
1118.1 (1022.2  
to 1329.8)
CTV, clinical target volume; IDC, invasive ductal carcinoma; DCIS, ductal carcinoma in situ; IQR, interquartile range (Q1, Q3).
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3. Analysis of motion-induced dosimetric effects 
To analyze the dosimetric effects of the intrafractional 
variation due to respiration with regard to the FIF tech-
nique, a dynamic FIF (DFIF) plan was generated; this plan 
reflects the motion measured by cine EPID onto the static 
FIF (SFIF) plan, which does not reflect organ motion. In 
other words, DFIF dose distribution was recalculated by 
adjusting the position of the sub-fields based on each 
patient’s specific movement values, as measured by cine 
EPID (the maximum amplitude of motion for the OBC 
and CW). We calculated the cumulative dose-volume 
histogram (DVH) for PTV and OARs from both SFIF and 
DFIF for all cases. Furthermore, for quantitative analysis of 
motion-induced dosimetric effects, the dose homogeneity 
index (DHI) for CTV and the percentage volume receiving 
over 20 Gy (V20) for the ipsilateral lung were calculated and 
compared for both techniques.18,20) 
DHI= D90
D10
DHI indicates dose uniformity within the CTV, and it is 
defined as the ratio of the treatment volume receiving 10% 
of the prescription dose (D10) to that receiving 90% (D90). A 
DHI value of 1 is an ideal value that indicates uniform dose 
distribution within the CTV. To assess whether there is sig-
nificant difference between the SFIF and DFIF, a Wilcoxon 
signed-rank test (version 9.4, SAS Institute, Cary, NC) was 
performed. A P-value of <0.05 was considered statistically 
significant.
Results
1. Measurement of intrafractional motion
We analyzed all 50 sets of cine EPID images obtained for 
the 10 patients and determined that the mean maximum 
motion amplitudes in all patients were 1.84±1.09 mm and 
0.69±0.50 mm along the X and Y directions in the OCB, 
respectively, and 1.88±1.07 mm and 1.66±1.49 mm in the 
CW, respectively (Table 2). When the motion of the CW 
was slightly greater than that of the OCB, the error along 
a b
Surrogate
Fig. 2. (a) In-house motion analysis 
soft ware and (b) the result of motion 
an alysis for whole-breast irradiation. 
Solid-lines (breast skin contour) and 
dotted (chest wall contour) boxes re-
pre sent surrogates for organ mo tion 
tracking based on a pattern match ing 
algorithm.
Table 2. Statistics of intrafractional movement from cine-EPID im-
ages obtained using in-house motion analysis software for whole-
breast irradiation
Patient
Movement of  
breast skin (mm)
Movement of  
chest wall (mm)
X Max. Y Max. X Max. Y Max.
1 5.53 0.84 5.22 1.69
2 3.13 2.08 2.61 6.79
3 1.57 1.55 2.09 2.58
4 2.68 0.52 2.23 1.07
5 1.57 1.04 1.57 3.66
6 1.65 0.450 2.13 1.00
7 2.61 2.08 2.08 2.08
8 0.54 0.54 1.17 0.66
9 3.24 0.92 3.35 1.73
10 1.69 0.45 1.73 0.76
Average 1.84 0.69 1.88 1.66
SD 1.09 0.50 1.07 1.49
Max 5.53 2.08 5.22 6.79
Max., maximum difference; X, perpendicular to tangential beam 
direction; Y, superior-inferior direction.
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the X direction was greater than that along the Y direction. 
The statistics of each patient’s motion showed a consider-
able difference. In patient #2, the CW motion was 6.79 mm 
along the Y direction, whereas it was 0.66 mm in patient #8, 
which corresponded to a large difference of about 6 mm. 
Moreover, patients with large OCB motion generally exhib-
ited large CW motion as well. Among all the patients, the 
maximum OCB motion amplitudes were 5.53 and 2.08 mm 
and the maximum CW motion amplitudes were 5.22 and 
6.79 mm along the X and Y directions, respectively.
2. Analysis of motion-induced dosimetric effects 
We used a total of 20 sub-fields in this study to perform 
the FIF plan, which corresponds to 2 sub-fields per patient 
on an average. In most patients, prominent improvement 
in the dose distribution, reduction in dose inhomogeneity 
within the target (white arrow in Fig. 3), and reduction in 
the lung dose (red arrow in Fig. 3b) were observed because 
of the addition of the sub-fields.
When the DFIF (Fig. 4b) was calculated by applying the 
maximum intrafractional movement measured from each 
patient to the SFIF (Fig. 4a), variations were observed not 
only in the dose distribution within the target but also in 
the lung dose (red arrow). Such a dose change was evident 
in the DVH. In one extreme case, the ipsilateral lung dose 
and target dose slightly increased (Fig. 5).
The mean DHI90/10 value for the target with SFIF for all 10 
patients was 0.94±0.01 (Table 3). The mean DHI90/10 with 
DFIF as generated for maximum movement along the +X 
direction was 0.94±0.01, and it was 0.95±0.01 along the -X 
direction. The mean DHI90/10 with DFIF as calculated for 
maximum movement along the +X and +Y directions si-
multaneously was 0.94±0.01 (P>0.05), and it was 0.95±0.01 
(P<0.05) for simultaneous maximum movement along the 
-X and -Y directions. However, the differences between all 
these values did not exceed 1%.
The V20 value of the ipsilateral lung with SFIF was 
19.00±7.16. The V20 values of the ipsilateral lung with DFIF 
were 18.89±7.16 and 19.21±7.17 for the maximum move-
ment along the +X and −X directions, respectively. Further-
more, the V20 value was 18.90±7.15 for simultaneous move-
ment along the +X and +Y directions, and it was 19.20±7.18 
for simultaneous movement along the -X and -Y directions 
(P<0.05). However, the differences between all these values 
did not exceed 1%.
a b
Fig. 3. Comparison of dose distribu-
tion (sagittal view) between the 
appli ca tion of (a) a conventional tan-
gen tial field and (b) a conventional 
field-in-field (FIF) boost technique. 
Regions subject to high dosage with 
the conventional field exhibited a 
signi fi cant reduction with the FIF 
tech nique (white arrow) along with 
signi fi cant reduction in the lung dose 
also (red arrow).
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Discussion
Many researchers have reported organ movement dur-
ing WBI. Saliou et al.21) obtained portal films of TI during 
treatment, analyzed the central lung distance (CLD), and 
reported movements of 0.8~10 mm along the anterior–
posterior direction. Smith et al. obtained a total of 1,709 
electronic portal images, analyzed the CLD, and observed 
a maximum CLD variation of 2.5 mm. This result indicates 
220 cGy
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200 cGy
194 cGy
190 cGy
170 cGy
150 cGy
100 cGy
50 cGy
a b
Fig. 4. Comparison of dose distribu-
tion between (a) static FIF (SFIF) and 
(b) dynamic FIF (DFIF). A partial 
dose increase in the lung (red arrow) 
and dose decrease in the target (white 
arrow) were observed for the DFIF 
plan because of organ motion.
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Fig. 5. An extreme example of dose-volume histogram (DVH) for 
target volume and lung. The ipsilateral lung dose and target dose 
increased slightly in dynamic FIF (DFIF, dotted line, applied maxi-
mum of the organ motion along -X direction) compared to static 
FIF (SFIF).
Table 3. Dose variation due to organ motion
Plan Movement
Average DHI90/10 
for target
Average V20 
for lung (%)
Static FIF None 0.94±0.01 19.00±7.16
Dynamic FIF X+max 0.94±0.01 18.89±7.16
X-max 0.95±0.01 19.21±7.17
XY+max 0.94±0.01 18.90±7.15
XY-max 0.95±0.01 19.20±7.18
DHI90/10, dose homogeneity index; SFIF, static field-in-field; 
DFIF+XYmax, dynamic field-in-field applied max. organ motion am-
pli tude along +X and +Y directions; DFIF-XYmax, dynamic field-in-
field applied max. organ motion amplitude along -X and -Y di rec-
tions.
A significant dif fer ence in DHI90/10 for CTV and V20 for lung was 
observed bet ween the SFIF and DFIF (P<0.05) in statistical 
analysis, but the dif fer ence in values was clinically acceptable.
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that little fluctuation was caused by breathing during treat-
ment.22) Baroni et al. attached markers on breast skin and 
monitored their motion in real time using an opto-elec-
tronic system. Their analysis on motion caused by breath-
ing during treatment showed that the median was consis-
tent at 2-3 mm and exhibited the highest value along the 
anterior–posterior direction.23) Richter et al. analyzed the 
motion of the chest using four-dimensional CT (4DCT) in 
10 patients, and the maximum motion amplitude was less 
than 4 mm in all patients. Furthermore, they compared the 
motion amplitude obtained via cine EPID images to that 
obtained via 4DCT. The results were similar in both cas-
es.24) In our study, we obtained an average motion of less 
than 2 mm, which was consistent with the results of other 
studies. However, the maximum amplitude of motion was 
significantly different from patient to patient. In addition, 
considerable motion was observed in some patients.
One of the demerits of treatment techniques that use 
sub-fields, such as IMRT and FIF, is that they are more sen-
sitive to dosimetric error by intrafractional motion than TI. 
Although the FIF uses only a few sub-fields, their influence 
cannot be completely excluded. The interplay effect, which 
is the mismatch between the target motion and delivery 
timing of these multiple sub-fields, is strongly associated 
with not only organ motion but also patient-specific con-
ditions including treatment techniques and anatomical 
geometry.25,26) The changes in dose distribution because of 
respiratory motion have been investigated in many stud-
ies. However, the results are inconsistent because these 
studies employed different types of information for do-
simetric evaluation instead of actual patient data.16,18,27,28) 
To overcome this issue, we evaluated the motion-induced 
dosimetric effects on the breast FIF technique by utilizing 
actual patient planning and organ motion data obtained 
from cine EPID images during treatment. Because of respi-
ration, the DHI of the target volume exhibited a maximum 
difference of 1.06%, and the dosage of the ipsilateral lung 
exhibited a partial increase when the sub-field was applied 
along the direction of the chest wall close to the lung. How-
ever, these differences were not clinically significant. 
To assess the motion-induced dosimetric error, accurate 
measurement of motion needs to be performed regularly. 
The cine EPID imaging used in this study does not require 
special equipment because only the treatment beam is 
used, and the method does not trigger additional radia-
tion exposure to patients. In particular, it is more effective 
for the breasts because the entire soft tissue of the breasts 
forms the treatment region and high-quality images can 
be obtained from the entire treatment field because of 
differences in density with respect to the lung behind the 
breasts.
We evaluated the effects of motion-induced dosimetric 
error by applying actual patient motion data that were ob-
tained via cine EPID images for FIF WBI. Dose variation 
with regard to the FIF technique due to respiratory organ 
motion was observed in both the target and lung volumes 
as per statistical analysis; however, the difference in values 
was clinically acceptable. Our findings indicate that FIF 
can form a safe and effective treatment method for the 
radiation treatment of breasts as it can improve dose distri-
bution within the target volume and reduce normal organ 
dose. We believe that the establishment of motion criteria 
and regular monitoring using cine EPID images can be ef-
fective in reducing motion-induced dosimetric errors.
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